StockMarketWire.com - Dietary supplements group OptiBiotix Health said it had extended the terms of an exclusive licence agreement with Australia's OptiPharm.
The agreement signed in March had granted OptiPharm exclusive use of the OptiBiome trademark in Australia, parts of Asia, New Zealand, the Middle East, Gulf States and North America.
The extension of terms now included Europe, with market exclusivity remaining linked to minimum order quantities.
At 1:37pm: [LON:OPTI] Optibiotix Health Plc share price was 0p at 55p
Story provided by StockMarketWire.com
Shares Magazine
Shares is the leading weekly publication for retail investors. It is packed with investment ideas, news and educational material to help build and run portfolios and get more from your money.
Investor Events
Shares puts on free Investor Events throughout the year across the country. They provide an opportunity for investors to learn more about companies on the stock market and hear from a range of investment experts including fund managers and Shares journalists.